MediciNova, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MNOV | MDNA.TO | MREO | GANX | BIVI | QNTM | |
|---|---|---|---|---|---|---|
| Market cap | 71.37M | 40.15M | 48.40M | 48.44M | 11.63M | 14.21M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -2.8 | -1.9 | -13.1 | -1.6 | -2.4 | -0.3 |
| Price/book | 1.9 | 24.2 | 1.7 | 4.3 | 1.0 | 2.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +3.57% | −70.81% | −82.78% | −37.50% | +11.61% | −75.44% |
| Today | +2.11% | +4.82% | +4.16% | −3.48% | −22.54% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MNOV news ›Comparing MediciNova (NASDAQ:MNOV) & CorMedix (NASDAQ:CRMD)
Posted by Mitch Edgeman on Oct 19th, 2026 MediciNova (NASDAQ:MNOV – Get Free Report) and CorMedix (NASDAQ:CRMD – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses…
Medici promotes in Paris
Global Arbitration Review Medici promotes in Paris Chiraz Abid, who serves as Tunisia’s delegate to the ICC Commission on Arbitration and ADR, has been promoted to counsel at Paris-based boutique Medici. Register for limited access…
MediciNova CEO Provides Shareholder Update
The Manila Times MediciNova CEO Provides Shareholder Update LA JOLLA, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the…
MediciNova Receives Notice Of Allowance For New Patent Covering Use Of MN-166 In Combination With Anti-PD-1 Immune Checkpoint Inhibitor For Glioblastoma Treatment
MediciNova, Inc. has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application that covers the use of ibudilast in combination with an immune... has received a Notice of Allowance from the…
MediciNova, Inc. Amends Lease and Extends End Date to April 30, 2030 with Newport Gateway Office LLC
MediciNova, Inc. amended its Lease, dated July 20, 2021, between the Company and Irvine Company LLC pursuant to a First Amendment to the Lease, dated as of September 23, 2026, by and between the... Pursuant to the Amendment, among other…
MediciNova to Participate in the Maxim Growth Summit
3iQ Receives In-Principal Approval from Abu Dhabi's IFC MediciNova (MNOV) announced that management will participate in the Maxim Growth Summit on October 12–14, 2026, in New York. MediciNova (MNOV) announced that management will…
MediciNova, Inc.: Official Announcements - Stock Market News
Find the latest press releases and official documents published by MediciNova, Inc. on MarketScreener. Press Releases MediciNova, Inc. Biotechnology & Medical Research All financial news and data tailored to specific country editions
MediciNova, Inc.: Relative Strength Chart - Stock Nasdaq
Compare MediciNova, Inc. with the company of your choice via a Relative Strength chart. Real-time MNOV price, Nasdaq stock exchange Relative Strength Chart MediciNova, Inc. Biotechnology & Medical Research All financial news and data…
MediciNova Granted US Patent Notice of Allowance for Ibudilast Combination to Treat Brain Cancer
MediciNova said Monday that it has received a pending patent notice of allowance from the US Patent and Trademark Office covering ibudilast in combination with an immune checkpoint inhibitor to... Biotechnology & Medical Research…
MediciNova, Inc.: Latest Headlines - Nasdaq Stock Exchange
Find the latest highlights on MediciNova, Inc. at the Nasdaq stock exchange. Biotechnology & Medical Research All financial news and data tailored to specific country editions
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com9
- manilatimes.net2
- stocktitan.net2
- globalarbitrationreview.com1
- globenewswire.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.